$AMLX
看空2022-03-28各周期结果✓ 命中-10.5%
1d
✗ +0.7%
5d
✓ -6.0%
21d
✓ -10.5%
原帖
Andy Biotech · 2022-03-28
$AMLX My quick take on FDA AdCom briefing doc Good news: No bombshell surprise. Bad news: The most appealing point of this drug to patients is the purported survival benefit, but FDA clearly doesn't buy into the claim due to multiple issues. https://t.co/phSXKsR3ig
在 X 查看 ↗